이 팟캐스트 소개 🔗

업데이트 빈도:
biweekly
평균 오디오 길이:
41 minutes
게스트 인터뷰
영어
캐나다
에피소드 39 개
2025년 5월 15일부터
episodic

최신 에피소드 🔗

Alberta is Canada’s first province to regulate psychedelic treatments, but when this change took effect in early 2023, it classified ketamine in the same category as psilocybin, MDMA, and LSD, under one “psychedelic-assisted psychotherapy” framework. So, what are the risks of lumping different psyc…

과거 에피소드 검색

The Integration Session의 과거 에피소드를 검색하세요.

이전 에피소드

What are the biggest gaps between psychedelic trials and what actually happens in the dosing room? And how might an Ayahuasca-inspired drug formulation affect shame and self-referential thinking? In this episode, we are joined by Dr. Helena Aicher, a research associate at the University of Zurich…
Therapeutic touch is often used in psychedelic therapy, but what ethical guidelines and boundaries should researchers and therapists follow? What can we learn from patient perspectives about consent, and where to draw the line? In this episode, Dr. Rachel Ham joins us from Monash University in Mel…
Psychedelics are often described as capable of “rewiring the brain,” but this leaves out a more complex and elegant series of mechanisms beneath the cortex. This episode goes a layer deeper to explore specific brain regions and receptors that are less often talked about in psychedelic science, desp…
What does it actually mean, physically, for a brain to be conscious, and what can psychedelics teach us about it? Can consciousness extend beyond living things, including artificial intelligence? In this episode of The Integration Session, we're joined by Dr. Adam Barrett, Associate Professor in …
What can two decades of clinical research teach us about psilocybin's potential for treating obsessive-compulsive disorder (OCD)? In this episode, we sit down with Dr. Francisco Moreno, a pioneer in psychedelic-assisted treatment research, to trace the arc of his work - from his landmark 2006 trial…
Want to stay updated on the latest advancements in psychedelic science without reading lengthy scientific papers? Welcome back to Research Recap, where Elena breaks down three recent studies in psychedelic science, in a digestible format. This episode covers a phase IIa trial of short-acting intrav…
Psychedelic treatments are often celebrated for their antidepressant potential, but emerging research suggests their effects go beyond traditional mood improvement. These compounds appear to work on multiple levels, prompting researchers to propose a more accurate term: “antidistressant.”  But what…
Psychedelics and psychosis have long been intertwined. Historically, psychedelics were more often called ‘psychotomimetics’ or compounds that temporarily mimic the symptoms of psychosis. But today, rather than modelling psychopathology, psychedelics are more often viewed as therapeutic tools in psy…
One of the most talked-about psychedelics in recent years is ibogaine, especially amidst recent policy shifts that aim to fast-track research progress in this area. While early evidence shows therapeutic potential for opioid addiction and PTSD in veterans, legitimate concerns remain regarding safet…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 The Centre for Psychedelics Health and Research에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.